Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Amneal Pharmaceuticals has announced the execution of an asset purchase agreement for Amneal's wholly-owned subsidiary, Amneal Pharmaceuticals of New York, to acquire the assets, facilities and business of Interpharm.
Subscribe to our email newsletter
Amneal has said it will use its leadership and financial position to fully realize the potential of Interpharm’s product line, ensure approval of its development pipeline and leverage the manufacturing capabilities.
Chintu Patel, CEO of Amneal, said: “Utilizing Amneal’s financial strength, superb quality management, R&D and manufacturing expertise with Interpharm’s outstanding facilities, leading market share and high value pipeline creates tremendous opportunities for rapid growth and exceptional customer satisfaction.”